New ACR guidelines on Gadolinium in End-Stage Renal Disease
Patients with any stage of renal disease should not receive the MR gadolinium contrast agent Omniscan, to help prevent a rare and life-threatening skin disease according to new, comprehensive MR Safe Practice Guidelines from the American College of Radiology.
Link to detailed guidelines here-
New ACR guidelines on Gadolinium in End-Stage Renal Disease
![]()
Reviewed by Sumer Sethi
on
Monday, March 05, 2007
Rating:
Sumer Sethi
Unique blend of academic excellence and entrepreneurship, heading leading firms in India- Teleradiology Providers, pioneering company providing teleradiology services and DAMS (Delhi Academy of Medical Sciences) Premier test preparation institute in India for MD/MS/MCI preparation. He has also been an invited faculty member at various conferences, including Teleradiology in IRIA 2008 and 2011, Hospital Build Middle East, Congress of the Brain Tumor Radiology in Neuro-oncology Society. Dr. Sethi is Editor-in-Chief of Internet Journal of Radiology. He has a keen interest in Web 2.0 technologies and in maintaining his famous radiology blog, which has been featured in multiple international journals.
1 comment:
Hi there! May I link my blog to this site? Thanks! :-)
www.ksdescartin.wordpress.com
Post a Comment